0001178031-17-000001.txt : 20170104 0001178031-17-000001.hdr.sgml : 20170104 20170104113803 ACCESSION NUMBER: 0001178031-17-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170104 DATE AS OF CHANGE: 20170104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SNYDERMAN RALPH CENTRAL INDEX KEY: 0001178031 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 17504076 MAIL ADDRESS: STREET 1: C/O SAIC STREET 2: 10260 CAMPUS POINT DR M/S F3 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2016-12-31 0 0001105533 ARGOS THERAPEUTICS INC ARGS 0001178031 SNYDERMAN RALPH C/O SAIC 10260 CAMPUS POINT DR M/S F3 SAN DIEGO CA 92121 1 0 0 0 Common Stock 2016-12-31 4 A 0 573 0 A 573 D The reporting person has received a fully vested stock award for shares of the Company's common stock. For calendar year 2016, the Company has elected to make common stock awards in lieu of cash payments of director fees otherwise payable under the director compensation policy. The number of shares of common stock awarded represent the quotient of (A) such director fees divided by (B) the Company's closing stock price on the date awarded, rounded down to the nearest whole share of common stock. /s/ Lori R. Harrelson, attorney-in-fact 2017-01-04